Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
Authors
Keywords
Prostate cancer, Cancer treatment, DU145 cells, Lymph nodes, Apoptosis, Mouse models, Small interfering RNAs, In vivo imaging
Journal
PLoS One
Volume 12, Issue 9, Pages e0184418
Publisher
Public Library of Science (PLoS)
Online
2017-09-09
DOI
10.1371/journal.pone.0184418
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7
- (2016) Wei Ren et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SOX9 drives WNT pathway activation in prostate cancer
- (2016) Fen Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition
- (2016) Chandra Prakash Prasad et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells
- (2015) Jian Wu et al. Journal of Translational Medicine
- Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells
- (2015) XIAOHUI PENG et al. ONCOLOGY REPORTS
- IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction
- (2015) Chong Chen et al. PROSTATE
- RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
- (2015) D. T. Miyamoto et al. SCIENCE
- The Regulation of Matrix Metalloproteinase Expression and the Role of Discoidin Domain Receptor 1/2 Signalling in Zoledronate-treated PC3 Cells
- (2015) Buket Reel et al. Journal of Cancer
- Enzalutamide (Xtandi) for Patients With Metastatic, Resistant Prostate Cancer
- (2014) Lunawati L. Bennett et al. ANNALS OF PHARMACOTHERAPY
- Androgens and androgen receptor signaling in prostate tumorigenesis
- (2014) Ye Zhou et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis
- (2014) Sourik S. Ganguly et al. Frontiers in Oncology
- Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
- (2014) Mannan Nouri et al. Frontiers in Oncology
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Is prostate cancer changing?: Evolving patterns of metastatic castration-resistant prostate cancer
- (2013) Stephanie M. Doctor et al. CANCER
- Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment
- (2013) Srikala S. Sridhar et al. EUROPEAN UROLOGY
- WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells
- (2013) Chandra Prakash Prasad et al. Molecular Oncology
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- WNT5A Inhibits Metastasis and Alters Splicing of Cd44 in Breast Cancer Cells
- (2013) Wen Jiang et al. PLoS One
- Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer
- (2012) Azharuddin Sajid Syed Khaja et al. Cancer Medicine
- Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates
- (2011) Sylvia Thiele et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome
- (2011) Azharuddin Sajid Syed Khaja et al. PLoS One
- Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase
- (2010) H Yamamoto et al. ONCOGENE
- International Union of Basic and Clinical Pharmacology. LXXX. The Class Frizzled Receptors
- (2010) G. Schulte PHARMACOLOGICAL REVIEWS
- Wnt-5a-CKIα Signaling Promotes β-Catenin/E-Cadherin Complex Formation and Intercellular Adhesion in Human Breast Epithelial Cells
- (2009) Catharina Medrek et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts
- (2009) Peter Jantscheff et al. PROSTATE
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
- (2009) William P Harris et al. Nature clinical practice. Urology
- The Wnt-5a-Derived Hexapeptide Foxy-5 Inhibits Breast Cancer Metastasis In vivo by Targeting Cell Motility
- (2008) A. Safholm et al. CLINICAL CANCER RESEARCH
- WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome
- (2008) P. D. Da Forno et al. CLINICAL CANCER RESEARCH
- Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
- (2007) Rebecka Hellsten et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started